Fc receptor-like 3 protein expressed on IL-2 nonresponsive subset of human regulatory T cells

Journal of Immunology

Volumn 182, Issue 12, 2009, Pages 7518-7526

  Nagata, Satoshi ^a,b   Ise, Tomoko ^a,b   Pastan, Ira ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SANFORD RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; FC RECEPTOR LIKE 3 PROTEIN; INTERLEUKIN 2; LYMPHOCYTE SURFACE MARKER; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; FCRL3 PROTEIN, HUMAN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; IMMUNOGLOBULIN RECEPTOR; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR ALPHA; LYMPHOCYTE ANTIGEN RECEPTOR; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; CD4+ CD25+ CD127 T LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; MALE; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; CELL CULTURE; CELL PROLIFERATION; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MIDDLE AGED;

ADULT; AGED; ANTIBODIES, MONOCLONAL; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-2; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-7 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, IMMUNOLOGIC; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA;

EID: 67649223627     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0802230     Document Type: Article

References (51)

1. Maltais, L. J., R. C. Lovering, A. V. Taranin, M. Colonna, J. V. Ravetch, R. Dalla-Favera, P. D. Burrows, M. D. Cooper, and R. S. Davis. 2006. New nomenclature for Fc receptor-like molecules. Nat. Immunol. 7: 431-432.
2. Davis, R. S. 2007. Fc receptor-like molecules. Annu. Rev. Immunol. 25: 525-560.
3. Ehrhardt, G. R., C. M. Leu, S. Zhang, G. Aksu, T. Jackson, C. Haga, J. T. Hsu, D. M. Schreeder, R. S. Davis, and M. D. Cooper. 2007. Fc receptor-like proteins (FCRL): immunomodulators of B cell function. Adv. Exp. Med. Biol. 596: 155-162.
4. Schreeder, D. M., J. Pan, F. J. Li, E. Vivier, and R. S. Davis. 2008. FCRL6 distinguishes mature cytotoxic lymphocytes and is upregulated in patients with B-cell chronic lymphocytic leukemia. Eur. J. Immunol. 38: 3159-3166.
5. Fayngerts, S. A., A. M. Najakshin, and A. V. Taranin. 2007. Species-specific evolution of the FcR family in endothermic vertebrates. Immunogenetics 59: 493-506.
6. Polson, A. G., B. Zheng, K. Elkins, W. Chang, C. Du, P. Dowd, L. Yen, C. Tan, J. A. Hongo, H. Koeppen, and A. Ebens. 2006. Expression pattern of the human FcRH/IRTA receptors in normal tissue and in B-chronic lymphocytic leukemia. Int. Immunol. 18: 1363-1373.
7. Davis, R. S., Y. H. Wang, H. Kubagawa, and M. D. Cooper. 2001. Identification of a family of Fc receptor homologs with preferential B cell expression. Proc. Natl. Acad. Sci. USA 98: 9772-9777.
8. Kochi, Y., R. Yamada, A. Suzuki, J. B. Harley, S. Shirasawa, T. Sawada, S. C. Bae, S. Tokuhiro, X. Chang, A. Sekine, et al. 2005. A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities. Nat. Genet. 37: 478-485.
9. + regulatory T cells. Immunol. Rev. 212: 60-73.
10. Sakaguchi, S., T. Yamaguchi, T. Nomura, and M. Ono. 2008. Regulatory T cells and immune tolerance. Cell 133: 775-787.
11. Vignali, D. A., L. W. Collison, and C. J. Workman. 2008. How regulatory T cells work. Nat. Rev. Immunol. 8: 523-532.
12. + regulatory T cells. Nat. Immunol. 4: 330-336.
13. Zheng, Y., S. Z. Josefowicz, A. Kas, T. T. Chu, M. A. Gavin, and A. Y. Rudensky. 2007. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 445: 936-940.
14. Marson, A., K. Kretschmer, G. M. Frampton, E. S. Jacobsen, J. K. Polansky, K. D. MacIsaac, S. S. Levine, E. Fraenkel, H. von Boehmer, and R. A. Young. 2007. Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature 445: 931-935.
15. Shevach, E. M., D. Q. Tran, T. S. Davidson, and J. Andersson. 2008. The critical contribution of TGF-β to the induction of Foxp3 expression and regulatory T cell function. Eur. J. Immunol. 38: 915-917.
16. Shevach, E. M., and G. L. Stephens. 2006. The GITR-GITRL interaction: co-stimulation or contrasuppression of regulatory activity? Nat. Rev. Immunol. 6: 613-618.
17. + regulatory T cell function. Science 322: 271-275.
18. Caruso, A., S. Licenziati, M. Corulli, A. D. Canaris, M. A. De Francesco, S. Fiorentini, L. Peroni, F. Fallacara, F. Dima, A. Balsari, and A. Turano. 1997. Flow cytometric analysis of activation markers on stimulated T cells and their correlation with cell proliferation. Cytometry 27: 71-76.
19. Huehn, J., K. Siegmund, and A. Hamann. 2005. Migration rules: functional properties of naive and effector/memory-like regulatory T cell subsets. Curr. Top. Microbiol. Immunol. 293: 89-114. (Pubitemid 40791226)
20. Allan, S. E., S. Q. Crome, N. K. Crellin, L. Passerini, T. S. Steiner, R. Bacchetta, M. G. Roncarolo, and M. K. Levings. 2007. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int. Immunol. 19: 345-354.
21. + T cells. Eur. J. Immunol. 37: 129-138.
22. + T cells in thymus, cord and adult blood. Immunology 106: 190-199.
23. + regulatory T cells. Semin. Immunol. 16: 89-98.
24. Seddiki, N., B. Santner-Nanan, J. Martinson, J. Zaunders, S. Sasson, A. Landay, M. Solomon, W. Selby, S. I. Alexander, R. Nanan, et al. 2006. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J. Exp. Med. 203: 1693-1700.
25. + Treg cells. J. Exp. Med. 203: 1701-1711.
26. + regulatory T cells express lower levels of the IL-7 receptor α chain (CD127), allowing consistent identification and sorting of live cells. J. Immunol. Methods 319: 41-52.
27. Du, X., S. Nagata, T. Ise, M. Stetler-Stevenson, and I. Pastan. 2008. FCRL1 on chronic lymphocytic leukemia, hairy cell leukemia, and B-cell non-Hodgkin lymphoma as a target of immunotoxins. Blood 111: 338-343.
28. Ise, T., H. Maeda, K. Santora, L. Xiang, R. J. Kreitman, I. Pastan, and S. Nagata. 2005. Immunoglobulin superfamily receptor translocation associated 2 protein on lymphoma cell lines and hairy cell leukemia cells detected by novel monoclonal antibodies. Clin. Cancer Res. 11: 87-96.
29. Nagata, S., G. Salvatore, and I. Pastan. 2003. DNA immunization followed by a single boost with cells: a protein-free immunization protocol for production of monoclonal antibodies against the native form of membrane proteins. J. Immunol. Methods 280: 59-72.
30. Nagata, S., T. Ise, M. Onda, K. Nakamura, M. Ho, A. Raubitschek, and I. H. Pastan. 2005. Cell membrane-specific epitopes on CD30: potentially superior targets for immunotherapy. Proc. Natl. Acad. Sci. USA 102: 7946-7951.
31. Trickett, A., and Y. L. Kwan. 2003. T cell stimulation and expansion using anti-CD3/CD28 beads. J. Immunol. Methods 275: 251-255.
32. Hoffman, R. A., and W. P. Hansen. 1981. Immunofluorescent analysis of blood cells by flow cytometry. Int. J. Immunopharmacol. 3: 249-254.
33. Mandy, F. F., M. Bergeron, D. Recktenwald, and C. A. Izaguirre. 1992. A simultaneous three-color T cell subsets analysis with single laser flow cytometers using T cell gating protocol: comparison with conventional two-color immunophenotyping method. J. Immunol. Methods 156: 151-162.
34. + T-cell counts on "single-platform" flow cytometers: I. Primary CD4 gating. Br. J. Haematol. 111: 1198-1208.
35. Herzenberg, L. A., J. Tung, W. A. Moore, and D. R. Parks. 2006. Interpreting flow cytometry data: a guide for the perplexed. Nat. Immunol. 7: 681-685.
36. + regulatory T cells in human thymus and periphery. Immunity 28: 870-880.
37. + and type 1 regulatory T cells. Curr. Top. Microbiol. Immunol. 293: 303-326.
38. Faria, A. M., and H. L. Weiner. 2005. Oral tolerance. Immunol. Rev. 206: 232-259.
39. + Treg. Eur. J. Immunol. 38: 912-915.
40. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188: 287-296.
41. + naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol. 10: 1969-1980.
42. + regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J. Exp. Med. 201: 723-735.
43. Burchill, M. A., J. Yang, K. B. Vang, and M. A. Farrar. 2007. Interleukin-2 receptor signaling in regulatory T cell development and homeostasis. Immunol. Lett. 114: 1-8.
44. Rao, P. E., A. L. Petrone, and P. D. Ponath. 2005. Differentiation and expansion of T cells with regulatory function from human peripheral lymphocytes by stimulation in the presence of TGF-β. J. Immunol. 174: 1446-1455.
45. Selvaraj, R. K., and T. L. Geiger. 2007. A kinetic and dynamic analysis of Foxp3 induced in T cells by TGF-β. J. Immunol. 178: 7667-7677.
46. + FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-β dependent but does not confer a regulatory phenotype. Blood 110: 2983-2990.
47. + T regulatory cells for immunosuppressive therapy. Cytometry A 75: 175-188.
48. + regulatory T-cell selection. Immunol. Rev. 212: 74-85.
49. Urry, Z., E. Xystrakis, D. F. Richards, J. McDonald, Z. Sattar, D. J. Cousins, C. J. Corrigan, E. Hickman, Z. Brown, and C. M. Hawrylowicz. 2009. Ligation of TLR9 induced on human IL-10-secreting Tregs by 1α,25- dihydroxyvitamin D3 abrogates regulatory function. J. Clin. Invest. 119: 387-398.
50. Newport, M., G. Sirugo, E. Lyons, F. Vannberg, A. V. S. Hill, L. A. Bradbury, C. Farrar, J. J. Pointon, P. Wordsworth, M. A. Brown, et al. 2007. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat. Genet. 39: 1329-1337.
51. Matesanz, F., O. Fernandez, R. L. Milne, M. Fedetz, L. Leyva, M. Guerrero, C. Delgado, M. Lucas, G. Izquierdo, and A. Alcina. 2008. The high producer variant of the Fc-receptor like-3 (FCRL3) gene is involved in protection against multiple sclerosis. J. Neuroimmunol. 195: 146-150.